Ob-Gyn Ultrasound and Fetal Monitoring
The role of ultrasound in obstetrics and gynecology has made tremendous impact in patient care. Ultrasound has permitted the imaging of the fetus and placenta in obstetrics and maternal internal organs in gynecology with very good clarity to allow advanced diagnosis and helped to guide various lifesaving interventions in both the cases of the fetus and the mother. The gynecology societies and associations and mainly the International Society of Ultrasound in Obstetrics and Gynecology and World Federation of Ultrasound in Medicine and Biology disapprove the use of ultrasound for the sole purpose of providing the souvenir images of the fetus which give a chance on knowing the gender of the fetus.
The current form of fetal monitoring was firstly introduced in the 1960s. Fetal monitoring was well established worldwide for monitoring pregnancies from ~26 weeks gestation right through to labor & delivery of the new born. Antenatally, pregnant women are monitored for, typically, 20 to 30 minutes at a time, repeated at intervals determined by their risk level. This will depend on their obstetric history, social factors, medical & clinical factors. In the UK, NICE have issued guidelines for trace interpretation, together with appropriate decision support & clinical management pathways. In labour, pregnant women are typically monitored continuously throughout labour, right up to delivery.
- Pelvic Ultrasound
- Transabdominal Sonography
- Transvaginal Sonography
- Amniotic fluid assessment
- Amniotic fluid assessment
- Ectopic pregnancy Scan protocol
- Fetal moment detector
- Fetal heart rate deceleration & ECG
- Maternal contractions
- Intrauterine pressure monitoring
Related Conference of Ob-Gyn Ultrasound and Fetal Monitoring
19th International Conference on Gynecology, Obstetrics and Womens Health
10th International Conference on Reproductive Health, Embryology and Fertility
7th International Conference on Womens Health, Reproduction and Fertility
Ob-Gyn Ultrasound and Fetal Monitoring Conference Speakers
Recommended Sessions
- Bleeding in first & late term of Pregnancy and intrapartum period
- Complications during Pregnancy
- Cosmetic Gynaecology
- Family planning
- Female Genitourinary Infections
- Gynecologic Oncology
- Gynecologic Surgery
- Gynecology & Obstetrics
- Humarn Reproduction, Reproductive Period & Reproductive Medicine
- Infections during Pregnancy
- Intrapartum and Postpartum Obsterics
- Maternal fetal medicine
- Menstrual Disturbances
- Midwifery
- Neonatology
- Ob-Gyn Ultrasound and Fetal Monitoring
- Pediatric and adolescent gynecology
- Postnatal care
- Prenatal care
- Reproductive Endocrinology and Infertility
- Sexual and Reproductive Health and Rights
- Stem Cells in Obstetrics And Gynecology
- Urogynecology
- Women Reproductive Cancers and Tumors
Related Journals
Are you interested in
- Abnormal Uterine Bleeding - GYNECOLOGY CONGRESS 2025 (Japan)
- Abortion and Miscarriage - WOMEN HEALTH SUMMIT 2025 (France)
- Adolescent and Maternal Health - GYNECOLOGY CONGRESS 2025 (Japan)
- Adolescent and Maternal Health - REPRODUCTION FERTILITY 2025 (Japan)
- Advancements in Gynaecology and Obstetrics - WOMEN HEALTH SUMMIT 2025 (France)
- Advances in Assisted Reproductive Technologies (ART) - Reproductive Medicine 2026 (France)
- Advances in Global Women Health - WOMEN HEALTH SUMMIT 2025 (France)
- Assisted Reproductive Technology - GYNECOLOGY CONGRESS 2025 (Japan)
- Biological effect of probiotics - World Probiotics 2025 (Canada)
- Birth Defects - WOMEN HEALTH SUMMIT 2025 (France)
- Complementary Therapies in Nursing and Midwifery - WOMEN HEALTH SUMMIT 2025 (France)
- COVID-19 - WOMEN HEALTH SUMMIT 2025 (France)
- Diagnostic & Therapeutic Applications of Ultrasound in Women's Healthcare - WOMEN HEALTH SUMMIT 2025 (France)
- Drug Management during Pregnancy - GYNECOLOGY CONGRESS 2025 (Japan)
- Drug Management during Pregnancy - REPRODUCTION FERTILITY 2025 (Japan)
- Drugs, Vaccines and Immunization for Children - WOMEN HEALTH SUMMIT 2025 (France)
- Endometriosis - GYNECOLOGY CONGRESS 2025 (Japan)
- Ethical, Legal, and Social Issues - GYNECOLOGY CONGRESS 2025 (Japan)
- Ethical, Legal, and Social Issues in Reproductive Health - Reproductive Medicine 2026 (France)
- Family Planning - WORLD MIDWIFERY CONGRESS 2025 (France)
- Female Reproductive Cancer - REPRODUCTION FERTILITY 2025 (Japan)
- Fertility & Infertility - REPRODUCTION FERTILITY 2025 (Japan)
- Fertility Preservation and Oncofertility - Reproductive Medicine 2026 (France)
- Fertility Surgery and IVF Treatment - REPRODUCTION FERTILITY 2025 (Japan)
- Future Technologies and Digital Health in Reproduction - Reproductive Medicine 2026 (France)
- Global Perspectives in Reproductive Health - Reproductive Medicine 2026 (France)
- Gynecologic cancers - WORLD MIDWIFERY CONGRESS 2025 (France)
- Gynecologic oncology - WOMEN HEALTH SUMMIT 2025 (France)
- Gynecologic Oncology - GYNECOLOGY CONGRESS 2025 (Japan)
- Gynecologic Surgeries - WORLD MIDWIFERY CONGRESS 2025 (France)
- Gynecological Endocrinology - GYNECOLOGY CONGRESS 2025 (Japan)
- Gynecology - WORLD MIDWIFERY CONGRESS 2025 (France)
- Gynecology and Obstetrics - WOMEN HEALTH SUMMIT 2025 (France)
- Health Risks Associated with Surrogacy - GYNECOLOGY CONGRESS 2025 (Japan)
- Hormonal Regulation and Endocrine Disorders - Reproductive Medicine 2026 (France)
- Impact of COVID-19 on Women’s Health - GYNECOLOGY CONGRESS 2025 (Japan)
- Importance of Women’s Heal - REPRODUCTION FERTILITY 2025 (Japan)
- Infertility - WOMEN HEALTH SUMMIT 2025 (France)
- Infertility - WORLD MIDWIFERY CONGRESS 2025 (France)
- Infertility - GYNECOLOGY CONGRESS 2025 (Japan)
- Innovations in Embryology and Laboratory Techniques - Reproductive Medicine 2026 (France)
- Latest Advancement in treatment - WOMEN HEALTH SUMMIT 2025 (France)
- Lifestyle, Environment, and Reproductive Health - Reproductive Medicine 2026 (France)
- Male and Female Contraception Innovations - Reproductive Medicine 2026 (France)
- Male Factor in Reproductive Medicine - REPRODUCTION FERTILITY 2025 (Japan)
- Male Infertility: Diagnosis and Treatment - Reproductive Medicine 2026 (France)
- Maternal health and Child health - WORLD MIDWIFERY CONGRESS 2025 (France)
- Maternal Health and Pregnancy Outcomes - Reproductive Medicine 2026 (France)
- Maternal-Fetal Medicine - GYNECOLOGY CONGRESS 2025 (Japan)
- Mechanisms of Probiotics - World Probiotics 2025 (Canada)
- Menopause and Healthy Aging in Women - REPRODUCTION FERTILITY 2025 (Japan)
- Menstrual Cycle and Ovulation - WOMEN HEALTH SUMMIT 2025 (France)
- Mental Health in Reproductive and Perinatal Life Stages - REPRODUCTION FERTILITY 2025 (Japan)
- Microbiome in Women’s Health and Fertility - REPRODUCTION FERTILITY 2025 (Japan)
- Midwifery - WORLD MIDWIFERY CONGRESS 2025 (France)
- Midwifery in Pediatrics - WORLD MIDWIFERY CONGRESS 2025 (France)
- Midwifery Nursing - WORLD MIDWIFERY CONGRESS 2025 (France)
- Multifetal Pregnancy - GYNECOLOGY CONGRESS 2025 (Japan)
- Neonatology - WORLD MIDWIFERY CONGRESS 2025 (France)
- Neuroendocrinology of Reproduction - REPRODUCTION FERTILITY 2025 (Japan)
- Nutrition and Metabolic Influences on Fertility - Reproductive Medicine 2026 (France)
- Obstetric Analgesia and Anesthesia - REPRODUCTION FERTILITY 2025 (Japan)
- Obstetrics - WORLD MIDWIFERY CONGRESS 2025 (France)
- Obstetrics, Gynecology, and Maternal Care - REPRODUCTION FERTILITY 2025 (Japan)
- PCOD & PCOS - GYNECOLOGY CONGRESS 2025 (Japan)
- Pediatric and Adolescent Reproductive Health - Reproductive Medicine 2026 (France)
- Perinatology - WORLD MIDWIFERY CONGRESS 2025 (France)
- Polycystic Ovary Syndrome - REPRODUCTION FERTILITY 2025 (Japan)
- Polycystic ovary syndrome (PCOS) - WOMEN HEALTH SUMMIT 2025 (France)
- Postnatal care - WORLD MIDWIFERY CONGRESS 2025 (France)
- Preconception & Care - WORLD MIDWIFERY CONGRESS 2025 (France)
- Pregnancy - WOMEN HEALTH SUMMIT 2025 (France)
- Pregnancy and its complications - WORLD MIDWIFERY CONGRESS 2025 (France)
- Prenatal care - WORLD MIDWIFERY CONGRESS 2025 (France)
- Prenatal Health line - WOMEN HEALTH SUMMIT 2025 (France)
- Preterm Birth and Prevention - GYNECOLOGY CONGRESS 2025 (Japan)
- Probiotics - World Probiotics 2025 (Canada)
- Psychological and Emotional Aspects of Infertility - Reproductive Medicine 2026 (France)
- Reproductive and Sexual Health - WORLD MIDWIFERY CONGRESS 2025 (France)
- Reproductive Endocrinology - REPRODUCTION FERTILITY 2025 (Japan)
- Reproductive Endocrinology - GYNECOLOGY CONGRESS 2025 (Japan)
- Reproductive Genetics and Genomics - Reproductive Medicine 2026 (France)
- Reproductive Immunology and Implantation - Reproductive Medicine 2026 (France)
- Reproductive Immunology and Implantation Science - REPRODUCTION FERTILITY 2025 (Japan)
- Reproductive Medicine - WORLD MIDWIFERY CONGRESS 2025 (France)
- Reproductive Medicine & Reproductive Toxicology - GYNECOLOGY CONGRESS 2025 (Japan)
- Reproductive Technologies and Precision Medicine - REPRODUCTION FERTILITY 2025 (Japan)
- Sexually Transmitted Diseases - GYNECOLOGY CONGRESS 2025 (Japan)
- Sexually Transmitted Infections - REPRODUCTION FERTILITY 2025 (Japan)
- Spontaneous Abortion and Miscarriage - GYNECOLOGY CONGRESS 2025 (Japan)
- Stem Cells and Regenerative Medicine - REPRODUCTION FERTILITY 2025 (Japan)
- Strains of Probiotics - World Probiotics 2025 (Canada)
- Urogynaecology - GYNECOLOGY CONGRESS 2025 (Japan)
- Women Health - WORLD MIDWIFERY CONGRESS 2025 (France)
- Women Oncology - WOMEN HEALTH SUMMIT 2025 (France)
- Women Oncology - WORLD MIDWIFERY CONGRESS 2025 (France)
- Women Reproductive Cancers - WOMEN HEALTH SUMMIT 2025 (France)
- Women's Health - WOMEN HEALTH SUMMIT 2025 (France)